More work to do on renin-angiotensin system blockade

Editorial

Yiming Z Lit et al. Clin J Am Soc Nephrol. 2006 Jul.

. 2006 Jul;1(4):611-3.

doi: 10.2215/CJN.01670506. Epub 2006 Jun 21.

No abstract available

Comment on

Aldosterone antagonism in chronic kidney disease.
Ponda MP, Hostetter TH. Ponda MP, et al. Clin J Am Soc Nephrol. 2006 Jul;1(4):668-77. doi: 10.2215/CJN.00120106. Epub 2006 May 17. Clin J Am Soc Nephrol. 2006. PMID: 17699271 Review. No abstract available.
Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.
Kanno Y, Takenaka T, Nakamura T, Suzuki H. Kanno Y, et al. Clin J Am Soc Nephrol. 2006 Jul;1(4):730-7. doi: 10.2215/CJN.01110905. Epub 2006 May 17. Clin J Am Soc Nephrol. 2006. PMID: 17699280 Clinical Trial.
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study.
Keane WF, Zhang Z, Lyle PA, Cooper ME, de Zeeuw D, Grunfeld JP, Lash JP, McGill JB, Mitch WE, Remuzzi G, Shahinfar S, Snapinn SM, Toto R, Brenner BM; RENAAL Study Investigators. Keane WF, et al. Clin J Am Soc Nephrol. 2006 Jul;1(4):761-7. doi: 10.2215/CJN.01381005. Epub 2006 May 17. Clin J Am Soc Nephrol. 2006. PMID: 17699284